Hudson Value Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
Hudson Value Partners's AMGN Position: Q2 2026 in Review
Hudson Value Partners increased its Amgen (AMGN) stake by 4.2% in Q2 2026, buying an estimated $291K and bringing the position to 21,171 shares worth $7.67M. The position accounts for 1.92% of the portfolio, ranked #16.
Hudson Value Partners first reported a position in AMGN in Q1 2023 and has held it in 14 quarters since. 1,278 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Hudson Value Partners held 21,171 shares of Amgen worth $7.67M as of Q2 2026.
- Hudson Value Partners bought 849 Amgen shares in Q2 2026, an estimated $291K.
- Amgen made up 1.92% of Hudson Value Partners's portfolio in Q2 2026, its #16 holding.
- Hudson Value Partners first reported a position in Amgen in Q1 2023 and has held it in 14 quarters since.
- 1,278 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Hudson Value Partners's 13F filing for Q2 2026, filed 10 Jul 2026.